司法部与Illumina就网络举报达成980万美元和解 - 医疗科技深度报道
DOJ reaches $9.8M settlement with Illumina over cyber whistleblower claims - MedTech Dive
#DOJ reaches#Dive DOJ#MedTech Dive#cyber whistleblower#whistleblower claims
生命科学资讯
生物技术与制药领域的最新动态
Illumina收购SomaLogic或面临类似GRAIL的监管障碍——ION Analytics报道
Illumina’s SomaLogic acquisition may face GRAIL-like regulatory hurdles - ION Analytics
#ION Analytics#SomaLogic acquisition#face GRAIL-like#GRAIL-like regulatory#Analytics Illumina
沃特斯公司公布2025年第二季度财务业绩——TradingView
Waters Corporation Reports Second Quarter 2025 Financial Results - TradingView
#Financial Results#Corporation Reports#Waters Corporation#Quarter#Financial
沃特斯公司股价触及52周新低，报279.51美元 - Investing.com
Waters Corporation stock hits 52-week low at 279.51 USD - Investing.com
#Waters Corporation#Corporation stock#stock hits#USD Investing.com#Investing.com Waters
沃特世公司（NYSE:WAT）第二季度销售额超预期，季度营收指引略高于预估——雅虎财经
Waters Corporation (NYSE:WAT) Posts Better-Than-Expected Sales In Q2, Quarterly Revenue Guidance Slightly Exceeds Expectations - Yahoo Finance
#Quarterly Revenue#Revenue Guidance#Guidance Slightly#Slightly Exceeds#Waters Corporation
沃特世公司(WAT)明日公布财报：市场预期如何——雅虎财经
Waters Corporation (WAT) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
#Reports Earnings#Earnings Tomorrow#Waters Corporation#Yahoo Finance#Expect Yahoo
司法部与Illumina就网络安全举报达成980万美元和解协议 - 网络安全要闻
DOJ reaches $9.8 million settlement with Illumina over cyber whistleblower claims - Cybersecurity Dive
#DOJ reaches#Cybersecurity Dive#million settlement#Dive DOJ#cyber whistleblower
Illumina公布2025财年第二季度财务业绩 - PR Newswire
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025 - PR Newswire
#Fiscal Year#Reports Financial#Financial Results#Illumina Reports#Newswire Illumina
临床前陷阱：如何避免代价高昂的配方失败——《自然》杂志
Preclinical pitfalls: How to avoid costly formulation failures - Nature
#Preclinical pitfalls#avoid costly#costly formulation#formulation failures#Nature Preclinical
Illumina升级旗舰检测方案，加速全面肿瘤谱分析应用进程 - 美通社
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling - PR Newswire
#Illumina enhances#enhances flagship#flagship assay#accelerate access#comprehensive tumor
Cytiva推出新型ÄKTA readyflux系统，专为小规模生产设计——选自SelectScience
Cytiva launches new ÄKTA readyflux system for smaller scale manufacturing - SelectScience
#ÄKTA readyflux#Cytiva launches#readyflux system#smaller scale#scale manufacturing
龙沙集团2025年上半年财报：营收超预期，每股收益符合预估——雅虎财经
Lonza Group First Half 2025 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
#Revenues Beat#Beat Expectations#Yahoo Finance#Lonza Group#Line Yahoo
拥抱韩国生命科学产业，引领下一代创新浪潮——亚洲生物光谱
Embracing Korea's life sciences industry as a powerhouse for next-generation innovation - BioSpectrum Asia
#Embracing Korea#Korea life#BioSpectrum Asia#life sciences#sciences industry
隆萨财报亮点：瓦卡维尔工厂表现突出——《瓦卡维尔记者报》
Vacaville facility a standout in Lonza earnings report - The Vacaville Reporter
#Vacaville Reporter#Lonza earnings#Vacaville facility#Reporter Vacaville#earnings report
罗氏在5,000名患者试验后放弃其TIGIT项目 | ApexOnco - 临床试验新闻与分析 - 肿瘤学研发管线
5,000 patients later Roche scraps its TIGIT | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
#Clinical Trials#Oncology Pipeline#Roche scraps#ApexOnco#analysis Oncology
罗氏CEO称正考虑直接向美国患者销售药品——路透社
Roche considering selling drugs directly to US patients, CEO says - Reuters
#selling drugs#drugs directly#Reuters Roche#CEO#patients
出版物聚焦：Kinnex长读RNA测序如何在转录水平定量上超越Illumina——PacBio
Publication spotlight: How Kinnex long-read RNA sequencing wins out over Illumina for transcript-level quantification - PacBio
#Kinnex long-read#long-read RNA#RNA sequencing#Publication spotlight#sequencing wins
龙沙集团在新战略下业绩回升，上调盈利预期——医药通讯
Lonza lifts forecast as performance rebounds under new strategy - The Pharma Letter
#Pharma Letter#Lonza lifts#lifts forecast#performance rebounds#Letter Lonza
瑞士公司收购基因泰克瓦卡维尔工厂——运营现状如何 - 旧金山商业时报 - 商业期刊
A Swiss company bought Genentech's Vacaville plant — here's how it's going so far - San Francisco Business Times - The Business Journals
#San Francisco#Genentech Vacaville#Francisco Business#Business Times#Business Journals
龙沙集团核心利润超预期，主要得益于其核心药物制造业务——路透社
Lonza tops core profit forecast driven by main drug manufacturing business - Reuters
#Lonza tops#tops core#core profit#profit forecast#forecast driven